R
Revyve
Functional yeast proteins that replace eggs in mainstream foods
About Revyve
Revyve is a Wageningen University & Research spin-out food-tech company that produces functional yeast proteins designed to replace eggs and additives in bakery, sauces, alternative meat and plant-based dairy while keeping clean-label, competitive pricing and lower environmental footprint. Led by CEO Cedric Verstraeten, the firm upcycles yeast into ingredients that mimic egg texture and performance for manufacturers facing volatile egg costs and ultra-processed-food scrutiny; its first-of-a-kind Dinteloord plant already runs at capacity for customers across Europe, the UK, North America, Mexico and Australia. In 2025 Revyve raised nearly €24 million in Series B financing co-led by ABN AMRO Sustainable Impact Fund and Invest-NL, with BOM, Danstar Ferment (Lallemand), Grey Silo Ventures and returning Oost NL and Royal Cosun, bringing total capital above €40 million to expand output beyond 1,600 tons per year. Sources: Revyve / PR Newswire 2025; StartLife; ABN AMRO SIF.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Wageningen, Netherlands
- Employees
- 45
- Open positions
- None listed
- Dealroom signal
- 79.7/100
- Sub-industry
- Innovative Food
- Sector
- Food, Food Processing, Biotechnology, Microbiology, Synthetic Biology, Vegan, Spinout, Food Waste, Alternative Protein
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2025 | $26M | $106M | BOM - Brabant Regional Development Agency · Oost NL - Eastern Netherlands Regional Development Agency · Lallemand Bio-Ingredients · ABN AMRO Bank | ↗ |
| SERIES A✓Equity / VC | May 2023 | $8.8M | $35M | Oost NL - Eastern Netherlands Regional Development Agency · Cosun Protein | ↗ |
Growth signals
Latest recorded traffic for Revyve is 4.9K monthly website visits, down 15.5% over the last three months. Revyve's team grew 9.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Oost NL - Eastern Netherlands Regional Development Agency
Cosun Protein
ABN AMRO Bank
BOM - Brabant Regional Development Agency
Lallemand Bio-Ingredients
Invest-NL
Cosun
Other known investors3 additional known investors
Wageningen University and Research
SHIFT Invest
StartLife
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Revyve on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Revyve’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







